Lifeline® Cell Technology Company Profile
Lifeline® Cell Technology (Lifeline®) develops, manufactures, and markets the highest quality cells, media, and reagents for the research marketplace. We take pride in our customer and technical service. Lifeline is a wholly owned subsidiary of International Stem Cell Corporation (ISCO, ISCO.OB), a California company that has developed breakthrough human stem cell lines that promise to eliminate the rejection of transplanted cells by the patient’s immune system. ISCO’s technology, Parthenogenesis, results in the creation of pluripotent human stem cell lines from unfertilized human eggs without the transfer of foreign DNA. International Stem Cell Corporation’s (ISCO) goal is to be the world’s leader in providing human cells to study and cure disease. ISCO will manufacture clinical and research products for the treatment of diabetes, liver disease and retinal disease.
Lifeline® customers are scientists working in major research organizations such as pharmaceutical companies, academic and government institutions. Lifeline® specialized products for the culture of human cells eliminate the need for each scientist to create his or her own media and reagents or try to adapt “off the shelf” products. Our modern laboratories and strict quality assurance provide the highest level of consistent value to the research community.
Please check back for our latest positions.